Bioasis Technologies (CVE:BTI) Sets New 12-Month Low at $0.01

Bioasis Technologies Inc. (CVE:BTIGet Free Report) shares reached a new 52-week low on Monday . The stock traded as low as C$0.01 and last traded at C$0.01, with a volume of 5250 shares trading hands. The stock had previously closed at C$0.01.

Bioasis Technologies Stock Down 50.0 %

The company has a debt-to-equity ratio of 27.88, a quick ratio of 0.17 and a current ratio of 0.11. The stock has a market cap of C$397,050.00, a price-to-earnings ratio of -0.13 and a beta of 0.42. The firm’s 50-day simple moving average is C$0.01 and its two-hundred day simple moving average is C$0.01.

Bioasis Technologies Company Profile

(Get Free Report)

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases.

Read More

Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.